KR20110134386A - 단일 세포의 세포독성을 평가하기 위한 조성물 및 방법 - Google Patents

단일 세포의 세포독성을 평가하기 위한 조성물 및 방법 Download PDF

Info

Publication number
KR20110134386A
KR20110134386A KR1020117018895A KR20117018895A KR20110134386A KR 20110134386 A KR20110134386 A KR 20110134386A KR 1020117018895 A KR1020117018895 A KR 1020117018895A KR 20117018895 A KR20117018895 A KR 20117018895A KR 20110134386 A KR20110134386 A KR 20110134386A
Authority
KR
South Korea
Prior art keywords
cells
cell
hiv
effector
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117018895A
Other languages
English (en)
Korean (ko)
Inventor
존 크리스토퍼 러브
나빈 바라다라잔
보리스 율크
브루스 워커
Original Assignee
메사추세츠 인스티튜트 오브 테크놀로지
더 제너럴 하스피털 코포레이션 두잉 비즈니스 애즈 매사츄세츠 제너럴 하스피털
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메사추세츠 인스티튜트 오브 테크놀로지, 더 제너럴 하스피털 코포레이션 두잉 비즈니스 애즈 매사츄세츠 제너럴 하스피털 filed Critical 메사추세츠 인스티튜트 오브 테크놀로지
Publication of KR20110134386A publication Critical patent/KR20110134386A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/06Methods of screening libraries by measuring effects on living organisms, tissues or cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
KR1020117018895A 2009-01-21 2009-07-13 단일 세포의 세포독성을 평가하기 위한 조성물 및 방법 Ceased KR20110134386A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14610609P 2009-01-21 2009-01-21
US61/146,106 2009-01-21

Publications (1)

Publication Number Publication Date
KR20110134386A true KR20110134386A (ko) 2011-12-14

Family

ID=42356144

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117018895A Ceased KR20110134386A (ko) 2009-01-21 2009-07-13 단일 세포의 세포독성을 평가하기 위한 조성물 및 방법

Country Status (11)

Country Link
US (1) US9244071B2 (enExample)
EP (1) EP2389446B1 (enExample)
JP (2) JP2012515548A (enExample)
KR (1) KR20110134386A (enExample)
CN (2) CN102388145A (enExample)
AU (1) AU2009338127B2 (enExample)
CA (1) CA2689681C (enExample)
IL (1) IL213938A0 (enExample)
RU (1) RU2532228C2 (enExample)
SG (2) SG172889A1 (enExample)
WO (1) WO2010085275A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2370814B1 (en) 2008-12-04 2015-04-29 Massachusetts Institute of Technology Method for diagnosing allergic reactions
US9404924B2 (en) 2008-12-04 2016-08-02 Massachusetts Institute Of Technology Method of performing one-step, single cell RT-PCR
AU2009338127B2 (en) 2009-01-21 2015-11-26 Massachusetts Institute Of Technology Compositions and methods for assessing cytotoxicity of single cells
EP2646798B1 (en) 2010-12-03 2017-06-28 Cellply S.R.L. Microanalysis of cellular function
EP2646830B1 (en) * 2010-12-03 2016-04-13 Cellply S.R.L. Rapid screening of monoclonal antibodies
CA2856868C (en) * 2011-12-13 2020-07-07 Single Cell Technology, Inc. Method of screening a plurality of single secreting cells for functional activity
US20150191772A1 (en) 2012-06-29 2015-07-09 Danmarks Tekniske Universitet Method of charging a test carrier and a test carrier
CN104884605B (zh) * 2012-08-24 2018-05-18 耶鲁大学 用于高通量多重检测的系统、装置和方法
EP3039162B1 (en) * 2013-08-26 2019-01-02 President and Fellows of Harvard College Determination of immune cells and other cells
US9877486B2 (en) 2014-01-31 2018-01-30 AgBiome, Inc. Methods of growing plants using modified biological control agents
US10508280B2 (en) 2014-01-31 2019-12-17 AgBiome, Inc. Modified biological control agents and their uses
EP3227684B1 (en) 2014-12-03 2019-10-02 Isoplexis Corporation Analysis and screening of cell secretion profiles
US10488321B2 (en) 2015-03-19 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Devices and methods for high-throughput single cell and biomolecule analysis and retrieval in a microfluidic chip
CN107667178A (zh) 2015-03-26 2018-02-06 休斯敦大学系统 细胞的整合功能和分子概况
WO2017124101A2 (en) 2016-01-15 2017-07-20 The Broad Institute Inc. Semi-permeable arrays for analyzing biological systems and methods of using same
WO2017165791A1 (en) 2016-03-25 2017-09-28 President And Fellows Of Harvard College Microfluidic determination of immune and other cells
WO2017169267A1 (ja) * 2016-03-30 2017-10-05 ソニー株式会社 細胞観察装置、免疫細胞の活性度の評価方法及び免疫細胞の品質管理方法
SG11201811104TA (en) 2016-06-14 2019-01-30 Cellply S R L Screening kit and method
CN106086171A (zh) * 2016-06-15 2016-11-09 广州中大南沙科技创新产业园有限公司 一种抑制肿瘤细胞增殖的药物筛选方法
EP3472351B1 (de) 2016-06-15 2020-10-28 Ludwig-Maximilians-Universität München Einzelmolekülnachweis bzw. -quantifizierung durch dna-nanotechnologie
EP3510398A1 (en) 2016-09-12 2019-07-17 Isoplexis Corporation System and methods for multiplexed analysis of cellular and other immunotherapeutics
EP3532600A4 (en) * 2016-10-19 2020-09-16 General Automation LAB Technologies Inc. HIGH RESOLUTION SYSTEMS, KITS, DEVICES AND METHODS FOR SCREENING MICRO-ORGANISMS AND OTHER HIGH-PERFORMANCE MICROBIOLOGICAL APPLICATIONS
US11493508B2 (en) 2016-11-11 2022-11-08 IsoPlexis Corporation Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells
US11085912B2 (en) * 2016-12-14 2021-08-10 University Of Cincinnati Methods of diagnosing Clostridium difficile infection or recurrence in a subject
SE543211C2 (en) 2017-06-29 2020-10-27 Mabtech Production Ab Method and system for analyzing Fluorospot assays
CA3084439A1 (en) 2017-12-07 2019-06-13 Massachusetts Institute Of Technology Single cell analyses
CN108728356B (zh) * 2018-05-23 2022-02-22 北京科技大学 用于不同三维细胞团配对的装置及共培养方法
CN113614532A (zh) * 2019-01-16 2021-11-05 烟台澳斯邦生物工程有限公司 沉积用于显微镜检查的生物样品的自动液体处理系统和方法
KR102800844B1 (ko) 2019-02-18 2025-04-29 가부시키가이샤 에누비 켄코우겡큐쇼 세포의 선발 방법, 핵산의 제조 방법, 재조합 세포의 제조 방법, 목적 물질의 제조 방법, 의약 조성물의 제조 방법, 및 시약
US12064768B2 (en) 2020-02-21 2024-08-20 Northeastern University Single cell isolation and processing system with reversible well shape
US20240182849A1 (en) 2022-11-07 2024-06-06 Shennon Biotechnologies Inc. Microfluidic Devices for High Throughput Screening of Cell-Cell Interactions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68507A (en) 1982-05-10 1986-01-31 Univ Bar Ilan System and methods for cell selection
SU1650094A1 (ru) * 1987-12-29 1991-05-23 Научно-исследовательский институт проктологии Способ диагностики прот женности активного воспалени в толстой кишке при неспецифическом звенном колите
US6410252B1 (en) 1995-12-22 2002-06-25 Case Western Reserve University Methods for measuring T cell cytokines
US6210910B1 (en) 1998-03-02 2001-04-03 Trustees Of Tufts College Optical fiber biosensor array comprising cell populations confined to microcavities
CA2370489A1 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 49 human secreted proteins
AU5591200A (en) * 1999-06-11 2001-01-02 Human Genome Sciences, Inc. 49 human secreted proteins
US7332286B2 (en) 2001-02-02 2008-02-19 University Of Pennsylvania Peptide or protein microassay method and apparatus
US20020141906A1 (en) 2001-03-30 2002-10-03 American Type Culture Collection Microtiter plate sealing cover with well identifiers
US7776553B2 (en) 2005-09-16 2010-08-17 Presidents And Fellows Of Harvard College Screening assays and methods
WO2009145925A1 (en) 2008-05-30 2009-12-03 Massachusetts Institute Of Technology Compositions and methods for spatial separation and screening of cells
US9404924B2 (en) 2008-12-04 2016-08-02 Massachusetts Institute Of Technology Method of performing one-step, single cell RT-PCR
EP2370814B1 (en) 2008-12-04 2015-04-29 Massachusetts Institute of Technology Method for diagnosing allergic reactions
AU2009338127B2 (en) 2009-01-21 2015-11-26 Massachusetts Institute Of Technology Compositions and methods for assessing cytotoxicity of single cells
US8569046B2 (en) 2009-02-20 2013-10-29 Massachusetts Institute Of Technology Microarray with microchannels

Also Published As

Publication number Publication date
US20120149592A1 (en) 2012-06-14
JP2012515548A (ja) 2012-07-12
AU2009338127A1 (en) 2011-07-28
WO2010085275A1 (en) 2010-07-29
SG10201401643PA (en) 2014-08-28
AU2009338127B2 (en) 2015-11-26
EP2389446A4 (en) 2012-10-03
SG172889A1 (en) 2011-08-29
CA2689681C (en) 2017-08-29
RU2532228C2 (ru) 2014-10-27
RU2011134898A (ru) 2013-02-27
JP2015144617A (ja) 2015-08-13
IL213938A0 (en) 2011-07-31
JP6017620B2 (ja) 2016-11-02
CN104745669A (zh) 2015-07-01
CN102388145A (zh) 2012-03-21
EP2389446B1 (en) 2017-07-05
EP2389446A1 (en) 2011-11-30
US9244071B2 (en) 2016-01-26
CA2689681A1 (en) 2010-07-21

Similar Documents

Publication Publication Date Title
EP2389446B1 (en) Compositions and methods for assessing cytotoxicity of single cells
Brenchley et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells
JP7711049B2 (ja) 初代ヒト細胞における、同族t細胞及びエピトープ反応性をスクリーニングするハイスループット法
US8975069B2 (en) Method for identifying antigen-specific regulatory T cells
Heutinck et al. Virus-specific CD8+ T cells cross-reactive to donor-alloantigen are transiently present in the circulation of kidney transplant recipients infected with CMV and/or EBV
Cohen et al. Clonotype tracking of TCR repertoires during chronic virus infections
Nyanhete et al. HLA class II-restricted CD8+ T cells in HIV-1 virus controllers
Anderko et al. IL-18 responsiveness defines limitations in immune help for specialized FcRγ–NK cells
van Dijk Single-cell based assessment of the human T cell response against Plasmodium falciparum circumsporozoite protein
Richard Toll-like receptor (TLR) 7 and TLR8 stimulation of mucosal-associated invariant T cells and gamma delta T cells: a role in HIV susceptibility
Iancu et al. Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T‐cells following therapeutic vaccination
Williams Role of TCR affinity in function, proliferation, memory generation, and exhaustion during human viral infection
De Simone Dissecting Functional Heterogeneity in the Human CD8+ T Cell Compartment to Characterize Superior Effector Responses
James Molecular and Cellular Mechanisms of Mycobacterial Glycolipid Recognition by Human T Cells
Razmi Killer Cell Immunoglobulin-Like Receptors Delineate Distinct Phenotypes and Functions in Human γδ T Cells
US20250116673A1 (en) Methods to determine cd4+ memory t cell responses to sars-cov-2 infection or vaccination
Brock et al. Role of TCR affinity in function, proliferation, memory generation, and exhaustion during human viral infection
van Dijk obtaining the doctoral degree
Phetsouphanh Novel approaches to the characterization of antigen-specific CD4+ T cells in HIV-1 infection
Parsons Lessons learned: natural killer cell education as a determinant of the anti-viral functional potential of natural killer cells
Combadière et al. High Cytotoxic and Specific Migratory
Wragg et al. High CD26 and Low CD94 Expression Identifies an IL-23 Responsive Vd2 T Cell Subset with a MAIT Cell-like Transcriptional Profile
Bruno Immune Checkpoints in Tumor Infiltrating Lymphocytes
Clutton HIV-specific interleukin-10 responses and immune modulation

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110812

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140707

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150916

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160627

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20150916

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I